In 2000, DLJMB acquired Focus Diagnostics, a scientifically driven infectious disease diagnostics company that has consistently been among the first to develop diagnostics for new infectious disease agents such as West Nile Virus and SARS. The fund exited the investment via a strategic sale in 2006 to Quest Diagnostics, the nation’s leading provider of diagnostic testing, information and services and Eurofins Scientific, a global leader in bio-analysis.
Location: United States, Virginia, Herndon
Investors 2
| Date | Name | Website |
| - | Avista Capital... | avistacap.com |
| - | New Leaf Ventu... | nlvpartners.co... |
Mentions in press and media 3
| Date | Title | Description | Source |
| 20.01.2012 | Multiple s... | The FDA also granted Weston, Massachusetts-based Biogen Iden a label change for Tysabri that updates... | medcitynew... |
| 19.05.2006 | Quest Diag... | Lyndhurst, NJ, and Herndon, VA, May 19, 2006 – PRNewswire-FirstCall — Quest Diagnostics Incorporated... | avistacap.... |
| - | Multiple s... | Multiple sclerosis patients using Biogen Idec (NASDAQ:BIIB) drug Tysabri now have access to the firs... | medcitynew... |